Navigation Links
ROX Medical secures financing and achieves key milestones in providing minimally-invasive approach for treating hypertension
Date:9/6/2012

SAN CLEMENTE, Calif., Sept. 6, 2012 /PRNewswire/ -- ROX Medical announced the closing of a financing round totaling $6M.  The financing will be used to initiate an international trial of the ROX FLOW procedure for the treatment of resistant hypertension (high blood pressure). Previously, ROX has successfully evaluated the FLOW procedure in pilot studies:  "The very encouraging results from our pilot hypertension trial was the basis for this investment, enabling us to pursue a more comprehensive, randomized study using the FLOW procedure," said CEO Rodney Brenneman.

According to the Centers for Disease Control, 68 million people in the US have high blood pressure and 1.2 billion people worldwide.  Of those, 50% of patients experience hypertension that remains uncontrolled (blood pressure above 140/90) and 15-20% have resistant form of hypertension. According to the American Heart Association, a 5 mmHg reduction in systolic blood pressure results in a 14% decrease in stroke, a 9% decrease in heart disease and a 7% decrease in overall mortality. 

ROX Medical's FLOW procedure is a short, minimally invasive, catheter-based procedure whereby Interventional Cardiologists, Radiologists or Endovascular Specialists place a stent-like connection between the artery and vein in the upper leg. The procedure is intended to reduce peripheral vascular resistance, thereby holding the promise of a meaningful long-term reduction in hypertension.  Uniquely, the FLOW procedure only involves the vascular structure, has an immediate effect; and is fully reversible.

To-date, ROX Medical has raised approximately $50M for its FLOW system, initially for studies and early commercialization of the FLOW procedure for COPD (pulmonary) treatment. The prior successful studies on COPD patients also demonstrated a significant lowering of blood pressure in hypertensive patients. "Hypertension physicians were encouraged by this response in our COPD patients, and pushed us to pursue this therapy separately for resistant hypertension patients as well.  We're excited to move forward with a randomized controlled trial," Brenneman said. Pilot results with the ROX FLOW procedure in resistant hypertensive patients have shown reductions in systolic and diastolic blood pressure on par with those for device therapies like renal denervation.

The ROX FLOW procedure for hypertension is not approved for use in the U.S.

Investors in the latest round of funding include continuing investors Domain Associates and Versant Ventures.


'/>"/>
SOURCE ROX Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
2. Medical Alarm Retires Last of Convertible Preferred Stock
3. Concord Medical Responds to Unusual Market Activity in its Stock
4. International Spine Products Manufacturer Featured in Upcoming US Business Executive Publication - www.gsmedicalusa.com
5. Medical Alarm Provides Investor Update -- Company Surpassing Previous Record Order Levels as Consumer Interest Accelerates
6. MyEvaluations.com Launches New Medical Education Management Solutions That Meet ACGME NAS Accreditation Requirements
7. Fall Alert Announces Its New Medical Alert Systems Website
8. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
9. Magnalight Releases Handheld Infrared Light for Medical Applications
10. GHX Selects MicroStrategy to Offer Healthcare Suppliers Enhanced Access to Distributed Medical-Surgical Market Data
11. Sacred Heart Medical Center Deploys Talysts Pharmacy Automation for Inventory Control and Improved Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
(Date:12/8/2016)... Dec. 8, 2016 True Health Diagnostics ... leading-edge laboratory services and management expertise to hospital ... , allowing more doctors and patients to benefit ... solutions. Logo - http://photos.prnewswire.com/prnh/20161208/447162LOGO ... systems, under pressure to contain costs, have struggled ...
(Date:12/8/2016)... -- Information products and services provider Elsevier ... , the world,s largest abstract and citation database of peer-reviewed literature, ... from over 5,000 publishers. The new set of metrics will improve ... when to adjust a journal,s editorial strategy. ... , , CiteScore ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... ... planning services from offices headquartered in Hamilton County, is embarking on a charity ... LuvFurMutts specializes in finding new homes for orphaned or neglected senior dogs in ...
(Date:12/8/2016)... , ... December 08, 2016 , ... The Compretta Insurance ... and residential clients in and around the Hancock County area, is announcing the launch ... County Food Pantry. , The Hancock County Food Pantry has worked for more than ...
(Date:12/7/2016)... Washington,DC (PRWEB) , ... December 07, 2016 , ... ... Forum (NYLF): Medicine will have the unique opportunity to get hands-on experience ... gives high school students an immersive experience to gain invaluable, real-life medical skills ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is ... by smoothing and tightening the skin of the face to create more youthful ... aging with very little downtime, Silhouette Instalift is a novel, minimally invasive facial ...
(Date:12/7/2016)... ... 2016 , ... In the early morning of October 30, Newton County Sheriff’s ... he lost control of his patrol car. The vehicle overturned into an embankment, causing ... to Atlanta Medical Center, where he later succumbed to his injuries. Justin White leaves ...
Breaking Medicine News(10 mins):